Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study

Gynecologic Oncology

Volumn 137, Issue 2, 2015, Pages 239-244

  Mahdi, Haider ^a   Elshaikh, Mohamed A ^b   DeBenardo, Robert ^a   Munkarah, Adnan ^b   Isrow, Derek ^b   Singh, Sareena ^c   Waggoner, Steven ^c   Ali Fehmi, Rouba ^d   Morris, Robort T ^d   Harding, Jarod ^e   Moslemi Kebria, Mehdi ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant therapy; Chemotherapy; Non invasive uterine papillary serous carcinoma; Outcome; Radiotherapy; Recurrence; Stage IA; Surgical staging

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OMENTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DISEASE FREE SURVIVAL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PELVIS; RADIATION RESPONSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; UTERINE NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 84933278723     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.01.544     Document Type: Article

References (21)

1. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer Mar 13 2006;94(5):642-6.
2. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol May 2004;11(3):117-42.
3. Cirisano Jr FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol Sep 1999;74(3):385-94.
4. Rosenberg P, Boeryd B, Simonsen E. A new aggressive treatment approach to highgrade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol Jan 1993;48(1):32-7.
5. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol Mar 1982;6(2):93-108.
6. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol Sep 1994;54(3):264-8.
7. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. Amorphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol Jun 1992;16(6):600-10.
8. O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol Apr 1990;37(1):112-9.
9. Chambers JT, Merino M, Kohorn EI, Peschel RE, Schwartz PE. Uterine papillary serous carcinoma. Obstet Gynecol Jan 1987;69(1):109-13.
10. Sutton GP, Brill L, Michael H, Stehman FB, Ehrlich CE. Malignant papillary lesions of the endometrium. Gynecol Oncol Jul 1987;27(3):294-304.
11. Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer May 15 2009;115(10):2119-27.
12. Kelly MG, O'Malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol Sep 2005;98(3):353-9.
13. Viswanathan AN, Macklin EA, Berkowitz R, Matulonis U. The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol Dec 2011;123(3):542-7.
14. Giuntoli II RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer Feb 2012;22(2):273-9.
15. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol Jul 2003;90(1):181-5.
16. Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol Jan 2005;18(1):75-82.
17. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, et al. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol 2007;107(2):285-91.
18. Secord AA, Geller MA, Broadwater G, et al. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. Gynecol Oncol 2013;128(1):65-70.
19. Huang CY, Tang YH, Chiang YC, Wang KL, Fu HC, Ke YM, Lau HY, Hsu KF, Wu CH, Cheng WF. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study. Gynecol Oncol May 2014;133(2):221-8.
20. Townamchai K1, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol Apr 2013;129(1):18-21.
21. Desai NB, Kiess AP, Kollmeier MA, Abu-Rustum NR, Makker V, Barakat RR, Alektiar KM. Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. Gynecol Oncol Dec 2013;131(3):604-8.